Tripelennamine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H21N3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FWV8GJ56ZN, chemically known as 1,2-ethanediamine, n, n-dimethyl-n- (phenylmethyl)-n-2-pyridinyl-, monohydrochloride but more generally known as tripelennamine hydrochloride, which bears US NIH Compound Identifier 5587. European Medicines Agency schedules Tripelennamine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04981MIG. Most nations, for tariff and trade purposes, schedule tripelennamine hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, TRIPELENNAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Tripelennamine hydrochloride bears US NLM identifiers UMLS ID C0304297 and NCI Concept Code C47774. SMILES: CN(C)CCN(CC1CCCCC1)C2CCCCN2.CL.